Product Information

TOPIRAMATE ER 100 MG SPRINK CAP is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $5.3819 per EA under NDC 68462037430. Its NADAC has been published 286 times since Mar 3, 2021.

FDA first approved this application on Feb 1, 2021. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TOPIRAMATE ER 100 MG SPRINK CAP

topiramate
$5.3819per EA

Strength

100 mg/1

NDC

68462037430

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TOPIRAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA210278

FDA Approved

2/1/2021

TE Code

AB2

On Market Since

2/1/2021

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for TOPIRAMATE ER 100 MG SPRINK CAP has been published 286 times since Mar 3, 2021, and over the history we have for it it has declined 68.3%. The table below summarizes its recorded NADAC range and movement.

Current price$5.3819 per EA
All-time high$17.6424 (Sep 15, 2021)
All-time low$5.3243 (Jul 22, 2026)
52-week high$8.8577
52-week low$5.3243
Median price$12.4006
Average price$12.4956
Largest weekly change+27.3% (Sep 20, 2023)
Weeks tracked286
Tracking sinceMar 3, 2021

Price History

1W

+1.1%

1M

+1.1%

3M

-5.0%

6M

-31.6%

1Y

-39.2%

3Y

-61.0%

5Y

-69.5%

All

-68.3%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TOPIRAMATE ER 100 MG SPRINK CAP?

The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE ER 100 MG SPRINK CAP, manufactured by Glenmark Pharmaceuticals Inc., USA, is $5.3819 per EA (NDC 68462037430), effective Aug 19, 2026.

How has the price of TOPIRAMATE ER 100 MG SPRINK CAP changed over time?

Over the history we have for it, the NADAC for TOPIRAMATE ER 100 MG SPRINK CAP has declined 68.3%. It has been tracked across 286 weekly CMS publications since Mar 3, 2021.

What are the highest and lowest recorded NADAC prices for TOPIRAMATE ER 100 MG SPRINK CAP?

Since Mar 3, 2021, the NADAC for TOPIRAMATE ER 100 MG SPRINK CAP has ranged from a low of $5.3243 (Jul 22, 2026) to a high of $17.6424 (Sep 15, 2021), with a median of $12.4006 per EA.

Are there cheaper alternatives to TOPIRAMATE ER 100 MG SPRINK CAP?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TOPIRAMATE ER 100 MG SPRINK CAP in a comparable dosage form, but none are currently priced below it.

Who manufactures TOPIRAMATE ER 100 MG SPRINK CAP?

TOPIRAMATE ER 100 MG SPRINK CAP (NDC 68462037430) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.